Report an error

Spotted something inaccurate in “Nivolumab After Lung Cancer Surgery Improves Survival in Phase III Trial”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.